Archives
- 2025-11
 - 2025-10
 - 2025-04
 - 2025-03
 - 2025-02
 - 2025-01
 - 2024-12
 - 2024-11
 - 2024-10
 - 2024-09
 - 2024-08
 - 2024-07
 - 2024-06
 - 2024-05
 - 2024-04
 - 2024-03
 - 2024-02
 - 2024-01
 - 2023-12
 - 2023-11
 - 2023-10
 - 2023-09
 - 2023-08
 - 2023-07
 - 2023-06
 - 2023-05
 - 2023-04
 - 2023-03
 - 2023-02
 - 2023-01
 - 2022-12
 - 2022-11
 - 2022-10
 - 2022-09
 - 2022-08
 - 2022-07
 - 2022-06
 - 2022-05
 - 2022-04
 - 2022-03
 - 2022-02
 - 2022-01
 - 2021-12
 - 2021-11
 - 2021-10
 - 2021-09
 - 2021-08
 - 2021-07
 - 2021-06
 - 2021-05
 - 2021-04
 - 2021-03
 - 2021-02
 - 2021-01
 - 2020-12
 - 2020-11
 - 2020-10
 - 2020-09
 - 2020-08
 - 2020-07
 - 2020-06
 - 2020-05
 - 2020-04
 - 2020-03
 - 2020-02
 - 2020-01
 - 2019-12
 - 2019-11
 - 2019-10
 - 2019-09
 - 2019-08
 - 2019-07
 - 2019-06
 - 2018-07
 
- 
                
          
br EBV Infection Epstein Barr virus
2020-08-13

EBV Infection Epstein–Barr virus (EBV, human herpesvirus 4) was discovered 50 years ago, when Epstein, Achong, and Barr used electron microscopy to identify viral particles in Burkitt\'s lymphoma cells. It belongs to the lymphocryptovirus (LCV) genus of the gammaherpesvirus subfamily (Fig. 1A). T
 - 
                
          
br Role of cysLT signaling on
2020-08-13

Role of cysLT signaling on various neurological complications which are associated with Alzheimer’s disease Alzheimer’s disease, first described in 1906 by Alois Alzheimer, is a neurodegenerative disease and a very common cause of dementia progressively leading to death. Even though years of rese
 - 
                
          
br Advantages of modified proteins over unmodified ones
2020-08-13

Advantages of modified proteins over unmodified ones In contrast to small-molecule drugs, proteins are readily amenable to site-specific alterations through genetic engineering. In principle, therefore, it is possible to build in features that allow them to remain active for longer in the body an
 - 
                
          
One of the therapeutic proteins used
2020-08-13

One of the therapeutic proteins used in cancer therapy is glucarpidase, also known as Carboxypeptidase G2, CPG2, which originates from the bacterium Variovorax paradoxus (old name, Pseudomonas sp. strain RS-16). It has no mammalian equivalent (Thompson et al., 1994; Kamlage, 1994) and is a zinc-depe
 - 
                
          
Wu et al explored the anti inflammatory mechanisms
2020-08-13

Wu et al. explored the anti-inflammatory mechanisms by which osthole 35 acted on HepG2 cells cultured in a differentiated medium from cultured 3T3-L1 preadipocyte cells. HepG2 cells, a human liver cell line, were treated with various concentrations of osthole 35 in differentiated media from cultured
 - 
                
          
br Conclusion and future perspectives LDL cholesterol loweri
2020-08-12

Conclusion and future perspectives LDL cholesterol-lowering therapy is essential for cardiovascular risk reduction. On the background of a high inter-personal variation of cholesterol synthesis and cholesterol CP-690550 Citrate the efficacy of cholesterol lowering, both, with statins and with ez
 - 
                
          
Mother rats acutely treated with quinpirole and
2020-08-11

Mother rats acutely treated with quinpirole (0.5 and 1.0 mg/kg) decreased the pup exploration time but increased the object exploration, so they showed a significantly lower pup preference ratio. They also showed impaired maternal performance in the home cage, consistent with our previous study (Zha
 - 
                
          
Abrahamson and coworkers recently demonstrated a distinct ro
2020-08-11

Abrahamson and coworkers (2009) recently demonstrated a distinct role of the podocyte in preservation and production of mature GBM-components such as α3/4/5(IV)-chains. This group further verified that collagen receptors (integrins) are linked to the Chlortetracycline HCl mg of podocytes. In accorda
 - 
                
          
Flexible alignment of isopropylphenylaminobenzimidazole with
2020-08-11

Flexible alignment of 7-isopropylphenylaminobenzimidazole 16 with the lead histamine-1 receptor antagonist 1 was performed using MOE. It was found that the aryl group of compound 16, exemplified as a yellow circle in Figure 2, overlapped well with the corresponding alkyl chain of compound 1 as well
 - 
                
          
br Introduction br Multiple levels of CK AKT cross talk
2020-08-11

Introduction Multiple levels of CK2/AKT cross-talk Isoform-specific signaling in CK2/AKT cross-talk Particularly relevant to the scope of this review, it has been shown that depletion of the CK2 catalytic α′ subunit is more effective than that of the α subunit at reducing AKT Ser129 phospho
 - 
                
          
This approach is similar to that suggested by the
2020-08-11

This approach is similar to that suggested by the previous edition of the GL [6]. Not surprisingly, the questions to be answered are the same (i.e., was the event TLOC? In cases of TLOC, is this Omecamtiv mecarbil of syncopal or non-syncopal origin? In cases of suspected syncope, is there a clear ae
 - 
                
          
Cytochrome P CYP enzymes plays
2020-08-10

Cytochrome P450 (CYP-450) enzymes plays an essential role in pharmacology of drugs and toxicology of xenobiotics. Inhibition of these enzymes may lead to increase plasma levels of a concomitantly administered drug (Lee et al., 2013). It may prolong or reduce the pharmacological effects and increase
 - 
                
          
The aim of the present study
2020-08-10

The aim of the present study was to investigate the participation of CRF1 and CRF2 in the alterations of the dorsal and ventral striatal dopamine release and the vertical and horizontal locomotor activity observed in rats following chronic nicotine treatment and consequent acute withdrawal. In this
 - 
                
          
We showed for the first time that ivermectin significantly
2020-08-10

We showed for the first time that ivermectin significantly reduced the pH-induced response of the pHCl-A variant at 300nM, whereas fipronil and γ-BHC had no significant effects on the channel unlike in RDL and GluCl (Fig. 4). Such a concentration is similar to the threshold at which ivermectin activ
 - 
                
          
EGTA In summary A is a potent orally available endothelin re
2020-08-10

In summary, A-216546 is a potent, orally available endothelin receptor antagonist with a high selectivity for the endothelin ETA receptor. The potency and bioavailability of A-216546 suggest that it will have important utility for preclinical evaluation of the pathophysiology of the endothelin syste
 
15000 records 774/1000 page Previous Next First page 上5页 771772773774775 下5页 Last page